openPR Logo
Press release

Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix

09-25-2024 08:18 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Neurological Biomarkers Market

Neurological Biomarkers Market

๐“๐ก๐ž ๐ซ๐ž๐œ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐›๐ฅ๐ข๐ฌ๐ก๐ž๐ ๐๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐”๐’๐ƒ ๐Ÿ–.๐Ÿ๐Ÿ— ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ‘.๐ŸŽ๐ŸŽ% ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.
๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐จ๐Ÿ๐Ÿ๐ž๐ซ ๐š๐ง ๐š๐›๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐”๐’๐ƒ ๐Ÿ๐Ÿ’.๐Ÿ–๐Ÿ‘ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

The need for neurological biomarkers has grown as a result of the growing existence of neurological illnesses involving conditions such as migraine, dementia, Alzheimer's disease, brain tumors, epilepsy, and others is confident of driving market augmentation. For instance, as per WHO, epilepsy causes roughly 13 million impairments calibrated life cycle and accounts for more than 0.5% of the global disease loads.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market/request-for-sample

Lately, biomarkers have been increasingly embraced in clinical patterns and clinical attempts in the area of neurology. The tempo of detection has been speeding due to technological progressions with escalated accuracy and susceptibility of the instrument and assays and cross-fertilization from one area of neurology to another. The weapons of biomarkers in neurology are prone to continue growing as the potential to estimate precisely manifold biological dynamics and knowhow about the pathophysiology of neurological illnesses escalate. They are utilized for many causes, to steer clinical diagnosis, to approximate illness probability or prognosis, to gauge illness phase, and to observe advancement or answer to therapy.

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐
The market is portrayed by fierce contention, with entrenched players depending on progressive technology, elevated standard commodities, and a robust brand image to push revenue growth.

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ฐ๐ก๐ข๐œ๐ก ๐š๐ซ๐ž ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐๐จ๐ฆ๐ข๐ง๐š๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:
โ€ข Abbott
โ€ข Alseres Pharmaceuticals, Inc.
โ€ข BANYAN BIOMARKERS, INC.
โ€ข Bio-Rad Laboratories, Inc.
โ€ข DiaGenic ASA
โ€ข Johnson & Johnson Services, Inc.
โ€ข Merck & Co., Inc.
โ€ข Myriad Genetics, Inc.
โ€ข Quanterix
โ€ข Thermo Fisher Scientific, Inc.

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/2965/0

๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ
โ€ข The primary factors propelling the market growth of neurological biomarkers are blood-based biomarkers, playing an important part in choosing relevant remedies and observing disease advancement.
โ€ข The neurological biomarkers market analysis is mainly based on type, application, end-use, and region.
โ€ข North America dominated the market.
โ€ข The market in Asia Pacific will increase as a result of the growth of clinical trials in surfacing nations such as China and India and a growing illness weight.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ
๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐ข๐ฆ๐š๐ซ๐ข๐ฅ๐ฒ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ญ๐ฒ๐ฉ๐ž, ๐š๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐ž๐ง๐-๐ฎ๐ฌ๐ž, ๐š๐ง๐ ๐ซ๐ž๐ ๐ข๐จ๐ง.
๐๐ฒ ๐“๐ฒ๐ฉ๐ž
โ€ข Metabolomic
โ€ข Genomic
โ€ข Imaging
โ€ข Proteomic
โ€ข Others

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ€ข Autism Spectrum Disorder
โ€ข Parkinson's Disease
โ€ข Alzheimer's Disease
โ€ข Multiple Sclerosis
โ€ข Others

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž
โ€ข Independent clinical diagnostic centers
โ€ข Research Organizations and Others
โ€ข Hospital & Hospital Laboratories

๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง
โ€ข North America (U.S., Canada)
โ€ข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โ€ข Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
โ€ข Latin America (Brazil, Mexico, Argentina)
โ€ข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐“๐จ๐ฉ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
โ€ข Offers a thorough analysis of neurological biomarkers market covering all the major aspects.
โ€ข Provides an estimation of the current, historical, and projected market size in terms of volume and value.
โ€ข Includes a detailed market segmentation covering all the major segments and sub-segments.
โ€ข An examination of the top market trends and developments has been provided in the report.
โ€ข Assesses the strategies of key market players and their product offerings.
โ€ข The study analyzes the changing market dynamics and classifies new partners or clients in the target demographic.

๐‚๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market

๐Š๐ž๐ฒ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐€๐ง๐ฌ๐ฐ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
โ€ข What is the current neurological biomarkers market size and forecast value?
โ€ข Who are the key players in the market?
โ€ข What are the opportunities and challenges market players might encounter?
โ€ข What are the key trends driving the market growth?
โ€ข At what CAGR is the market anticipated to grow?
โ€ข What is the estimated demand for different types of products/services in the market?

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
๐Ž๐ฑ๐ข๐๐š๐ญ๐ข๐ฏ๐ž ๐’๐ญ๐ซ๐ž๐ฌ๐ฌ ๐€๐ฌ๐ฌ๐š๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/oxidative-stress-assay-market

๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/regulatory-information-management-system-market

๐”.๐’. ๐ƒ๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/us-diabetes-devices-market

๐€๐ฅ๐ฅ๐ž๐ซ๐ ๐ฒ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/allergy-diagnostics-market

๐†๐ฅ๐ฎ๐œ๐จ๐ฌ๐ž ๐๐ข๐จ๐ฌ๐ž๐ง๐ฌ๐จ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/glucose-biosensors-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
๐‹๐ข๐ค๐ก๐ข๐ฅ ๐†
8 The Green Ste 19824,
Dover, DE 19901,
United States
๐๐ก๐จ๐ง๐ž:+1-929 297-9727
๐„๐ฆ๐š๐ข๐ฅ: sales@polarismarketresearch.com
๐–๐ž๐›: https://www.polarismarketresearch.com
๐…๐จ๐ฅ๐ฅ๐จ๐ฐ ๐”๐ฌ: LinkedIn | Twitter

๐€๐›๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก & ๐‚๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐ˆ๐ง๐œ:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix here

News-ID: 3666777 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Gene Therapy Market Growth Projection: USD 29.01 Billion Valuation by 2035 at 27.1% CAGR
12-11-2025 | Health & Medicine
Polaris Market Research & Consulting
Gene Therapy Market Growth Projection: USD 29.01 Billion Valuation by 2035 at 27 โ€ฆ
The quantitative market research report published by Polaris Market Research on Gene Therapy Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Gene Therapy Market size, financial data, and projected future growth. All the information presentedโ€ฆ
Europe Armor Materials Market to Reach USD 6.09 Billion by 2034, Growing at 7.0% CAGR
12-10-2025 | Chemicals & Materials
Polaris Market Research & Consulting
Europe Armor Materials Market to Reach USD 6.09 Billion by 2034, Growing at 7.0% โ€ฆ
Market Size and Share: Europe Armor Materials Market is currently valued at USD 3.10 billion in 2024 and is anticipated to generate an estimated revenue of USD 6.09 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Polaris Market Research has introduced the latest market researchโ€ฆ
Europe Antibody Specificity Testing Market Projected to Hit USD 433.81 Million by 2034, Growing at a CAGR of 7.3%
12-10-2025 | Health & Medicine
Polaris Market Research & Consulting
Europe Antibody Specificity Testing Market Projected to Hit USD 433.81 Million b โ€ฆ
The quantitative market research report published by Polaris Market Research on Europe Antibody Specificity Testing Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Europe Antibody Specificity Testing Market size, financial data, and projected future growth.โ€ฆ
U.S. Extended Detection and Response (XDR) Market to Reach USD 24.86 Billion by 2034, Advancing at a CAGR of 30.6%
12-10-2025 | IT, New Media & Software
Polaris Market Research & Consulting
U.S. Extended Detection and Response (XDR) Market to Reach USD 24.86 Billion by โ€ฆ
The quantitative market research report published by Polaris Market Research on U.S. Extended Detection and Response (XDR) Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, U.S. Extended Detection and Response (XDR) Market size, financial data,โ€ฆ

All 5 Releases


More Releases for Neurological

11-17-2025 | Health & Medicine
The Business Research Company
Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomar โ€ฆ
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Neurological Biomarkers Market Through 2025? The valuation of the neurological biomarkers market has experienced swift expansion lately, projected to increase from its standing of $10.7 billion in 2024 to reach $11.92 billion by 2025, reflecting an eleven-point-four percent compound annual growth rate;โ€ฆ
07-17-2025 | Health & Medicine
The Business Research Company
Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growthโ€ฆ
09-26-2024 | Health & Medicine
Data Bridge Market Research
Neurological Biomarkers Market : An Overview
Introduction: Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans forโ€ฆ
05-07-2024 | Health & Medicine
Accute Market Research
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder โ€ฆ
๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง: Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, andโ€ฆ
06-15-2023 | Business, Economy, Finances, B โ€ฆ
Growth Plus Reports
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi โ€ฆ
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,โ€ฆ
06-05-2023 | Business, Economy, Finances, B โ€ฆ
Growth Plus Reports
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov โ€ฆ
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview ofโ€ฆ